Literature DB >> 2400945

Biochemical modulation of 5-fluorouracil by PALA.

P J O'Dwyer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400945     DOI: 10.3109/07357909009017577

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  2 in total

1.  Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group study.

Authors:  R L Martino; T R Fleming; L M Morrell; B Ardalan; S P Richman; J S Macdonald
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.

Authors:  Shannon K Tomlinson; Susan A Melin; Vetta Higgs; Douglas R White; Paul Savage; Douglas Case; A William Blackstock
Journal:  BMC Cancer       Date:  2002-05-02       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.